SEP
ELAN icon

Signature Equity Partners’s Elanco Animal Health ELAN Stock Holding History

Signature Equity Partners’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Sell
4,140
-1,917
-32% -$44.3K 0.05% 296
2026
Q1 		$145K Buy
6,057
+5,919
+4,289% +$145K 0.08% 232
2025
Q4 		$3.12K Buy
+138
New +$3K ﹤0.01% 1109

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Signature Equity Partners's ELAN Position: Q2 2026 in Review

Signature Equity Partners reduced its Elanco Animal Health (ELAN) stake by 32% in Q2 2026, selling an estimated $44.3K and leaving 4,140 shares worth $102K. The position accounts for 0.05% of the portfolio, ranked #296.

Signature Equity Partners first reported a position in ELAN in Q4 2025 and has held it in 3 quarters since. The position peaked at $145K in Q1 2026. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Signature Equity Partners held 4,140 shares of Elanco Animal Health worth $102K as of Q2 2026.
  • Signature Equity Partners sold 1,917 Elanco Animal Health shares in Q2 2026, an estimated $44.3K.
  • Elanco Animal Health made up 0.05% of Signature Equity Partners's portfolio in Q2 2026, its #296 holding.
  • Signature Equity Partners first reported a position in Elanco Animal Health in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Elanco Animal Health position peaked at $145K in Q1 2026.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.